MAPK8IP3mitogen-activated protein kinase 8 interacting protein 3
Autism Reports / Total Reports
8 / 11Rare Variants / Common Variants
24 / 0Aliases
-Associated Syndromes
-Chromosome Band
16p13.3Associated Disorders
-Relevance to Autism
In a report describing 32 individuals with pathogenic or likely pathogenic MAPK8IP3 variants recruited through the Cure MAPK8IP3 Foundation, Sudnawa et al., 2025 found that, in addition to phenotypes frequently associated with neurodevelopmental disorder with or without variable brain abnormalities (NEDBA; OMIM 618443), autism was observed in 31.3% of individuals in this cohort. Previous reports describing individuals with NEDBA found a diagnosis of autism spectrum disorder in 2/13 patients in Platzer et al., 2019 and autistic behavior in 2/5 patients in Iwasawa et al., 2019; both reports also demonstrated functional effects of patient-associated MAPK8IP3 variants in C. elegans and zebrafish. A number of de novo missense variants in the MAPK8IP3 gene have been reported in ASD probands, including a p.Tyr94Cys variant originally identified in an SSC proband that was experimentally shown to result in an adverse locomotion phenotype in C. elegans in Platzer et al., 2019 (Iossifov et al., 2014; Yuen et al., 2017; Zhou et al., 2022; Trost et al., 2022), while a de novo MAPK8IP3 nonsense variant was identified in a Chinese ASD proband in Wang et al., 2023.
Molecular Function
The protein encoded by this gene shares similarity with the product of Drosophila syd gene, required for the functional interaction of kinesin I with axonal cargo. Studies of the similar gene in mouse suggested that this protein may interact with, and regulate the activity of numerous protein kinases of the JNK signaling pathway, and thus function as a scaffold protein in neuronal cells. The C. elegans counterpart of this gene is found to regulate synaptic vesicle transport possibly by integrating JNK signaling and kinesin-1 transport.
SFARI Genomic Platforms
Reports related to MAPK8IP3 (11 Reports)
| # | Type | Title | Author, Year | Autism Report | Associated Disorders |
|---|---|---|---|---|---|
| 1 | Support | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
| 2 | Support | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder | C Yuen RK et al. (2017) | Yes | - |
| 3 | Support | - | Konrad Platzer et al. (2019) | No | ASD |
| 4 | Support | - | Shinya Iwasawa et al. (2019) | No | Autistic behavior |
| 5 | Support | Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort | Callaghan DB , et al. (2019) | Yes | - |
| 6 | Support | Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks | Ruzzo EK , et al. (2019) | Yes | - |
| 7 | Support | - | Zhou X et al. (2022) | Yes | - |
| 8 | Support | - | Fu JM et al. (2022) | Yes | - |
| 9 | Support | - | Trost B et al. (2022) | Yes | - |
| 10 | Support | - | Wang J et al. (2023) | Yes | - |
| 11 | Primary | - | Khemika K Sudnawa et al. () | No | ASD |
Rare Variants (24)
| Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
|---|---|---|---|---|---|---|---|---|
| c.399G>A | p.Thr133= | synonymous_variant | De novo | - | - | 35982160 | Fu JM et al. (2022) | |
| c.79G>T | p.Glu27Ter | stop_gained | De novo | - | - | 30612693 | Konrad Platzer et al. (2019) | |
| c.741C>A | p.Tyr247Ter | stop_gained | De novo | - | Simplex | 37393044 | Wang J et al. (2023) | |
| c.343C>G | p.Leu115Val | missense_variant | De novo | - | Unknown | 35982159 | Zhou X et al. (2022) | |
| c.1198G>A | p.Gly400Arg | missense_variant | De novo | - | - | 30612693 | Konrad Platzer et al. (2019) | |
| c.1331T>C | p.Leu444Pro | missense_variant | De novo | - | - | 30612693 | Konrad Platzer et al. (2019) | |
| c.1574G>A | p.Arg525Gln | missense_variant | De novo | - | - | 30612693 | Konrad Platzer et al. (2019) | |
| c.2982C>G | p.His994Gln | missense_variant | De novo | - | - | 30612693 | Konrad Platzer et al. (2019) | |
| c.1732C>T | p.Arg578Cys | missense_variant | De novo | - | - | 30945334 | Shinya Iwasawa et al. (2019) | |
| c.111C>G | p.Tyr37Ter | stop_gained | De novo | - | Simplex | 30612693 | Konrad Platzer et al. (2019) | |
| c.3373G>A | p.Val1125Met | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
| c.3883C>T | p.Arg1295Cys | missense_variant | De novo | - | Unknown | 35982159 | Zhou X et al. (2022) | |
| c.3436C>T | p.Arg1146Cys | missense_variant | De novo | - | - | 30945334 | Shinya Iwasawa et al. (2019) | |
| c.1230C>T | p.Arg410= | synonymous_variant | De novo | - | Multiplex | 35982159 | Zhou X et al. (2022) | |
| c.281A>G | p.Tyr94Cys | missense_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
| c.1775C>T | p.Pro592Leu | missense_variant | De novo | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
| c.3050C>T | p.Ala1017Val | missense_variant | De novo | - | Multiplex | 36368308 | Trost B et al. (2022) | |
| c.3715G>A | p.Val1239Met | missense_variant | De novo | - | Multiplex | 36368308 | Trost B et al. (2022) | |
| c.691G>A | p.Asp231Asn | missense_variant | Unknown | - | Simplex | 31038196 | Callaghan DB , et al. (2019) | |
| c.1732C>T | p.Arg578Cys | missense_variant | De novo | - | Simplex | 30612693 | Konrad Platzer et al. (2019) | |
| c.3436C>T | p.Arg1146Cys | missense_variant | De novo | - | Simplex | 30612693 | Konrad Platzer et al. (2019) | |
| c.1732C>T | p.Arg578Cys | missense_variant | De novo | - | Multiplex | 30945334 | Shinya Iwasawa et al. (2019) | |
| c.65del | p.Gly22AlafsTer3 | frameshift_variant | De novo | - | Simplex | 30612693 | Konrad Platzer et al. (2019) | |
| delGAGACGGAGAGGACGAC | p.Gly1298fs | frameshift_variant | Familial | Paternal | Multiplex | 31398340 | Ruzzo EK , et al. (2019) |
Common Variants
No common variants reported.
SFARI Gene score
Strong Candidate, Syndromic

criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
10/1/2025
Initial score established: 2S
Krishnan Probability Score
Score 0.49683708520251
Ranking 2496/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99999997092263
Ranking 161/18225 scored genes
[Show Scoring Methodology]
Iossifov Probability Score
Score 0.846
Ranking 195/239 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.94761075939622
Ranking 17346/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.17568581615935
Ranking 4699/20870 scored genes
[Show Scoring Methodology]
CNVs associated with MAPK8IP3(1 CNVs)
Sort By:
| 16p13.3 | 73 | Deletion-Duplication | 103 / 544 |